Outcomes Rocket

Cancer is not one disease, which means it cannot be addressed by one type of treatment or research.In this episode, Chris Learn, Vice President of Cell and Gene Therapy at Parexel, talks about oncology research, cell and gene therapies, and the patients’ journey navigating this space. Chris discusses next-generation therapies and the challenges common sites may face in adopting them.Tune in to learn more about cancer research and treatment developments from Chris!Click this link to the show notes, transcript, and resources: outcomesrocket.health

Techquity is becoming a standard expectation in today’s healthcare industry.In this episode, we are honored to feature Alexis Anderson, Principal at Ipsos Healthcare Advisory, and Theresa Demeter, Manager Director at Tegria. Both of them have an experienced journey in the healthcare industry, implementing technology in healthcare and avoiding the increase of current disparities, and they are now working in a coalition to improve techquity industry-wide. Tune in to this information-packed episode about the standard practices of healthcare!Click this link to the show notes, transcript, and resources: outcomesrocket.health

Working together towards health equity.In this episode, Kyle talks with Kati Sadiwnyk, Head of Innovation and Diabetes Portfolio at Sanofi, about how she’s advocating for patient access, affordability, and equity. She explains what the partnership with DarioHealth seeks to bring and how each company is using its areas of expertise in a combined way to deliver the best care to the patients. She details what each party brings to the partnership and how it seeks to improve outcomes and much more.Listen to what Kati says about patient advocacy and Sanofi's work to improve health equity!Click this link to the show notes, transcript, and resources: outcomesrocket.health

An Operations team can upscale an entire company by providing a steady framework for growth.In this episode, Matt Meiners talks about the importance of lab operations management from infrastructure and teamwork from his experience at EpiCypher. Matt emphasizes why documentation is key for a manufacturing lab and how even a small database can provide clarity and save time in the long run. Tune in to this episode and learn more about how operations enhance this bioscience company!Click this link to the show notes, transcript, and resources: outcomesrocket.health

The physician's role is changing, and here’s a cardiologist’s perspective on what’s coming down the road.In this episode, Scott Roth, co-founder, CEO, and Chief Medical Officer at ImaCor, questions the current medical education system with a full-circle conversation based on his experience in cardiology, the transition to team-based care with a value-based model, and the evolution of noninvasive imagery technologies. Healthcare industry incentives have changed in the past decades, and so Dr. Roth discusses how motivation is a challenge that should be addressed by the educational system and supported with a value-based model.Tune in to learn more about the evolution of echocardiology and the role of physicians in healthcare!Click this link to the show notes, transcript, and resources: outcomesrocket.health

We need to redefine healthcare for businesses to treat it properly.In this episode, Simon Gisby discusses how to build a business that adds value to healthcare focusing on the customers. He questions what we have defined as healthcare and broadens its definition to cover humans' physical, mental, spiritual, and financial status, amongst other possible environmental determinants. If healthcare were treated as something preventive, taking into account these social determinants would be beneficial, as Simon highlights.Tune in and listen to what Simon Gisby has to say about the future of healthcare with how platform businesses can change health ecosystems for the better!Click this link to the show notes, transcript, and resources: outcomesrocket.health

Technology is disrupting the traditional way of developing drugs for the better.In this episode, Behzad Mahdavi discusses the groundbreaking work with the Ginkgo platform technology to optimize drug discovery and manufacture with highly automated biological experiments. This process enables the rapid development of new advanced therapies in a safe, faster, and cheaper manufacturing setting. He also shares how any company within the pharma industry seeking to optimize drug development can use the Ginkgo platform.Tune in to learn more about Ginkgo’s work and resources for development optimization!Click this link to the show notes, transcript, and resources: outcomesrocket.health

It’s all about getting to the customer!Join us for an insightful conversation with Matt Tucker as he shares his expertise on MedTech commercialization, pharmaceutical, and device marketing. Discover how to connect authentically with customers, understand their needs, and improve their lives through your product or service. Gain valuable insights into traditional pharma marketing vs. device marketing, and learn about incentives and customer insights that can drive product growth and enhance the customer experience. Tune in to this episode to learn more about MedTech and how it can help you reach your customers!Click this link to the show notes, transcript, and resources: outcomesrocket.health

Yes, we take care of patients, but we must remember to care for our staff.This week on the SONSIEL Podcast, Brittany Drumm and Dawn Snyder discuss the importance of a peer support network for nurses and how they’re implementing an innovative pet therapy program for the cause at Geisinger. Nurses’ value is immeasurable, and so creating systems that make their lives a little bit easier can help them flourish and be even more innovative than they already are.Tune in and learn about Geisinger's work to improve nurses’ work experience!Click this link to the show notes, transcript, and resources: outcomesrocket.health

Although people dealing with rare diseases may be few, they all share a common humanity with the broader population that must be considered when designing trials.In this episode, Seth Rotberg, co-founder of Our Odyssey, talks about his journey with Huntington’s disease and his take on how clinical research could improve the experience of the patient community. He shares the story of his mother’s misdiagnosis and how he discovered he was a disease carrier, discussing how the clinical research space can repair its reputation and create a trusting relationship with the community.Tune in to learn more about the roller coaster Seth has gone through and the lessons he is sharing from his ride!Click this link to the show notes, transcript, and resources: outcomesrocket.health